Jacobio Pharmaceuticals Group Co., Ltd.
HKEX:1167.HK
1.75 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 11.593 | 11.593 | 20.168 | 20.168 | 20.53 | 20.53 | 27.344 | 27.344 | 47.56 | 47.56 | 28.845 | 28.845 | 243.143 | 243.143 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 11.192 | 11.192 | 18.967 | 18.967 | 18.629 | 18.629 | 22.927 | 22.927 | 43.423 | 43.423 | 26.567 | 26.567 | 22.058 | 22.058 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.401 | 0.401 | 1.201 | 1.201 | 1.901 | 1.901 | 4.417 | 4.417 | 4.137 | 4.137 | 2.278 | 2.278 | 221.086 | 221.086 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.035 | 0.035 | 0.06 | 0.06 | 0.093 | 0.093 | 0.162 | 0.162 | 0.087 | 0.087 | 0.079 | 0.079 | 0.909 | 0.909 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 86.784 | 86.784 | 99.376 | 99.376 | 134.529 | 134.529 | 88.295 | 88.295 | 79.589 | 79.589 | 60.83 | 60.83 | 57.47 | 57.47 | 35.506 | 35.506 | 42.424 | 42.424 | 27.065 | 27.065 |
| General & Administrative Expenses
| 11.45 | 11.45 | 11.858 | 11.858 | 9.886 | 9.886 | 11.39 | 11.39 | 13.025 | 13.025 | 9.264 | 9.264 | 20.732 | 20.732 | 6.187 | 6.187 | 32.115 | 32.115 | 3.425 | 3.425 |
| Selling & Marketing Expenses
| 0 | 0 | 13.702 | 0 | 11.652 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.45 | 11.45 | 11.858 | 11.858 | 9.886 | 9.886 | 11.39 | 11.39 | 13.025 | 13.025 | 9.264 | 9.264 | 20.732 | 20.732 | 6.187 | 6.187 | 32.115 | 32.115 | 3.425 | 3.425 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 107.058 | 107.058 | 93.483 | 93.483 | 131.294 | 131.294 | 72.124 | 72.124 | 91.86 | 91.86 | 74.247 | 74.247 | 573.291 | 573.291 | 406.058 | 406.058 | 136.253 | 136.253 | 78.848 | 78.848 |
| Operating Income
| -94.924 | -94.924 | -111.054 | -111.054 | -146.367 | -146.367 | -94.096 | -94.096 | -81.504 | -81.504 | -64.653 | -64.653 | 145.14 | 145.14 | -40.053 | -40.053 | -71.159 | -71.159 | -29.059 | -29.059 |
| Operating Income Ratio
| -8.188 | -8.188 | -5.507 | -5.507 | -7.13 | -7.13 | -3.441 | -3.441 | -1.714 | -1.714 | -2.241 | -2.241 | 0.597 | 0.597 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.496 | -1.496 | 27.913 | 27.913 | 24.349 | 24.349 | 30.183 | 30.183 | -0.792 | -0.792 | -3.645 | -3.645 | -496.527 | -496.527 | -365.399 | -365.399 | -64.222 | -64.222 | -48.469 | -48.469 |
| Income Before Tax
| -96.419 | -96.419 | -83.141 | -83.141 | -122.018 | -122.018 | -63.913 | -63.913 | -82.295 | -82.295 | -68.299 | -68.299 | -351.387 | -351.387 | -405.452 | -405.452 | -135.381 | -135.381 | -77.528 | -77.528 |
| Income Before Tax Ratio
| -8.317 | -8.317 | -4.122 | -4.122 | -5.944 | -5.944 | -2.337 | -2.337 | -1.73 | -1.73 | -2.368 | -2.368 | -1.445 | -1.445 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.007 | -0.007 | -0.004 | -0.004 | -0.034 | -0.034 | -0.469 | -0.469 |
| Net Income
| -96.419 | -96.419 | -83.141 | -83.141 | -122.018 | -122.018 | -63.913 | -63.913 | -82.295 | -82.295 | -68.299 | -68.299 | -351.38 | -351.38 | -405.448 | -405.448 | -135.347 | -135.347 | -77.059 | -77.059 |
| Net Income Ratio
| -8.317 | -8.317 | -4.122 | -4.122 | -5.944 | -5.944 | -2.337 | -2.337 | -1.73 | -1.73 | -2.368 | -2.368 | -1.445 | -1.445 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.12 | -0.12 | -0.11 | -0.11 | -0.16 | -0.16 | -0.085 | -0.085 | -0.11 | -0.11 | -0.092 | -0.092 | -0.82 | -0.82 | -1.21 | -1.21 | -0.62 | -0.62 | -0.35 | -0.35 |
| EPS Diluted
| -0.12 | -0.12 | -0.11 | -0.11 | -0.16 | -0.16 | -0.085 | -0.085 | -0.11 | -0.11 | -0.092 | -0.092 | -0.82 | -0.82 | -1.21 | -1.21 | -0.62 | -0.62 | -0.35 | -0.35 |
| EBITDA
| -94.487 | -94.487 | -106.076 | -106.076 | -145.965 | -145.965 | -90.892 | -90.892 | -80.576 | -80.576 | -62.211 | -62.211 | 145.571 | 145.571 | -37.617 | -37.617 | -69.695 | -69.695 | -25.891 | -25.891 |
| EBITDA Ratio
| -8.151 | -8.151 | -5.26 | -5.26 | -7.11 | -7.11 | -3.324 | -3.324 | -1.694 | -1.694 | -2.157 | -2.157 | 0.599 | 0.599 | 0 | 0 | 0 | 0 | 0 | 0 |